166 related articles for article (PubMed ID: 2208572)
1. Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture.
Matsumoto M; Tihan T; Cory JG
Cancer Chemother Pharmacol; 1990; 26(5):323-9. PubMed ID: 2208572
[TBL] [Abstract][Full Text] [Related]
2. The utility of combinations of drugs directed at specific sites of the same target enzyme--ribonucleotide reductase as the model.
Cory JG; Sato A; Carter GL; Bacon PE; Montgomery JA; Brown NC
Adv Enzyme Regul; 1985; 23():181-92. PubMed ID: 3907303
[TBL] [Abstract][Full Text] [Related]
3. Effects of combinations of drugs having different modes of action at the ribonucleotide reductase site on growth of L1210 cells in culture.
Sato A; Carter GL; Bacon PE; Cory JG
Cancer Res; 1982 Nov; 42(11):4353-7. PubMed ID: 6751522
[TBL] [Abstract][Full Text] [Related]
4. Effects of biochemical modulation of drug combinations directed at the ribonucleotide reductase site on leukemia L1210 cell growth in culture.
Sato A; Carter GL; Bacon PE; Cory JG
Adv Enzyme Regul; 1983; 21():259-70. PubMed ID: 6400064
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
Sato A; Cory JG
Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
[TBL] [Abstract][Full Text] [Related]
6. Cross-resistance patterns in hydroxyurea-resistant leukemia L1210 cells.
Carter GL; Cory JG
Cancer Res; 1988 Oct; 48(20):5796-9. PubMed ID: 2844392
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
Matsumoto M; Weckbecker G; Cory JG
Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
[TBL] [Abstract][Full Text] [Related]
8. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
Cory AH; Samano V; Robins MJ; Cory JG
Biochem Pharmacol; 1994 Jan; 47(2):365-71. PubMed ID: 8304981
[TBL] [Abstract][Full Text] [Related]
9. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
Cory JG; Carter GL
Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
[TBL] [Abstract][Full Text] [Related]
10. Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.
Lin AL; Elford HL
J Biol Chem; 1980 Sep; 255(18):8523-8. PubMed ID: 6997299
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cells.
Weckbecker G; Weckbecker A; Lien EJ; Cory JG
J Natl Cancer Inst; 1988 Jun; 80(7):491-6. PubMed ID: 2452889
[TBL] [Abstract][Full Text] [Related]
12. Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase.
Carter GL; Cory JG
Adv Enzyme Regul; 1989; 29():123-39. PubMed ID: 2699151
[TBL] [Abstract][Full Text] [Related]
13. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
14. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
Wilson JM; Mitchell BS; Daddona PE; Kelley WN
J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N'-aminoguanidine derivatives.
Matsumoto M; Fox JG; Wang PH; Koneru PB; Lien EJ; Cory JG
Biochem Pharmacol; 1990 Oct; 40(8):1779-83. PubMed ID: 2242014
[TBL] [Abstract][Full Text] [Related]
16. Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
Sato A; Bacon PE; Cory JG
Adv Enzyme Regul; 1984; 22():231-41. PubMed ID: 6089512
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of drug resistance to inhibitors directed at the individual subunits of ribonucleotide reductase.
Carter GL; Thompson DP; Cory JG
Cancer Commun; 1989; 1(1):13-20. PubMed ID: 2701080
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
Spector T; Jones TE
J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
[TBL] [Abstract][Full Text] [Related]
19. Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth.
Slabaugh MB; Howell ML; Wang Y; Mathews CK
J Virol; 1991 May; 65(5):2290-8. PubMed ID: 2016760
[TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of leukemia L1210 cell growth in vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2,3-dihydro-1H-pyrazole[2,3-a]imidazole.
Sato A; Montgomery JA; Cory JG
Cancer Res; 1984 Aug; 44(8):3286-90. PubMed ID: 6611198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]